The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry
Search this site
12276 results found with an empty search
- Dole to sell Progressive Produce unit for $120m
Dole has reached an agreement to sell its 65% equity stake in Progressive Produce to PTF Holdings, a portfolio company of Arable Capital Partners, for a sum of $120.25 million. Located in Los Angeles, California, US, Progressive Produce serves as a grower, packer and distributor of both conventional and organic produce to the retail, wholesale and foodservice markets across the US and Canada. Founded in 1967, the business is said to have evolved into "one of California's premier produce companies," with annual sales surpassing $400 million. Following the conclusion of this transaction, the current Progressive Produce management team will remain on board with the enlarged business of Progressive Produce and Pacific Trellis Fruit. Additionally, they will maintain an ownership stake in the business. Carl McCann, executive chairman of Dole, said: “We are pleased to announce the sale of our equity interest in Progressive Produce to Arable Capital Partners. Since our initial investment in 2016, the business has been a strong performer within our Group." "...The proceeds from this sale will further strengthen our financial position and enhance the group’s focus on, and investments in, our core activities.” Derek Yurosek, managing director of Arable Capital Partners, added: “Arable is thrilled about the opportunity to partner with Progressive Produce. The company is a leader in top produce categories and has an impressive and diversified customer base, as well as an exceptional team. We look forward to helping Progressive Produce continue to deliver outstanding products and service to its retail, wholesale and foodservice customers." "While Progressive Produce and Pacific Trellis Fruit will continue to operate independently, we are excited about the chance for them to work together to continue to grow their businesses and ultimately bring even greater value to their grower partners and customers. This is a fantastic outcome for everyone involved.” The transaction, which is expected to close next month, is subject to the satisfaction of customary closing conditions. Dole expects that the net proceeds from the sale will primarily be directed towards reducing debt.
- Dole collaborates with Beam Be Amazing on Super Greens blend
Dole Food Company has joined forces with clean supplement brand Beam Be Amazing to expand its presence in the health and wellness. The partnership kicks off with the launch of 'Beam x Dole Super Greens,' featuring orange, peach and mango flavours infused with a blend of 35 fruits and vegetables per serving, along with prebiotic fibre, digestive enzymes, antioxidants, essential vitamins and minerals. The new launch is free from artificial sweeteners or colours, and is non-GMO, gluten-free and soy-free. The blend comes in powder format and can be added to beverages or food. The NPD also contains Spectra, which Beam Be Amazing explains is a “clinically proven formula that helps increase antioxidants in your body, improve your immune system and improve overall cellular health”. Elisabeth Morris, director for brand and licensing at Dole Food Company, added: “We are thrilled to partner with Beam to leverage Dole’s bold flavours and bring a taste of paradise to everyone in a new way! Beam’s focus on educating consumers aligns so well with our mission at Dole around nutritional education. We hope that this product will encourage more people on their health and wellness journey.” Russell Saks, CEO of Beam Be Amazing, said: “Since the inception of our Super Greens product, we have always thought Dole was a natural fit for a product collaboration. We couldn't be more excited to partner with a company that not only makes great products but shares our values and mission, as well.” Beam also forged a partnership with popular juice brand Sunny D, collaborating to create a nostalgic blend that offers consumers an all-encompassing wellness formula for their daily routines.
- Cathedral City launches smoked and red leicester cheeses
Saputo Dairy UK brand Cathedral City has launched a new ‘Best of British’ range featuring two new cheese products, ‘Our Naturally Smoked Cheddar’ and ‘Our Red Leicester’. In a statement announcing the launch, Saputo Dairy said that the move marks the first time a naturally smoked cheddar has launched in the pre-pack cheese aisle in UK supermarkets. Cathedral City’s cheese is made in Cornwall with milk from West Country Farms. The brand said its process of naturally smoking the new product ensures the cheese’s texture and quality is preserved as well as resulting in a better flavour throughout. Louise Reuby, controller of innovation for cheese at Saputo Dairy UK, said: “Naturally smoked over oak chips, it’s a perfectly balanced, delicate smoked cheese, which is testament to our ongoing commitment to innovation, and we are incredibly proud to be one of the first to introduce this on-trend flavour to the category”. She added that the addition of red leicester was a natural choice, responding to a “clear opportunity to bring a branded offering to the market”. Both SKUs are available in a 300g block format and launched in 210 Sainsbury’s stores on 13 September. Smoked will also be available in 482 Morrison’s stores from 2 October.
- Saputo enters into 15-year power purchase agreement with Capital Power
Dairy giant Saputo has entered into a 15-year virtual power purchase agreement (VPPA) with North American power producer Capital Power. The long-term deal, which is supported by energy procurement advisor Schneider Electric, is part of Saputo’s sustainability efforts. The agreement pertains to a Canada-based wind facility, named Halkirk 2 Wind, which is currently under construction. Once operational, the portion of the wind facility contracted by Saputo will generate around 206,300 MWh of renewable electricity annually. This is set to reduce the dairy giant’s CO2 emissions by more than 140,000 tonnes. The VPPA is expected to reduce Saputo’s global CO2 footprint by 13%, compared to its fiscal 2020 baseline. Carl Colizza, Saputo’s president and COO of North America, said: “It is vital we demonstrate our commitment to the long-term sustainability of the dairy industry. This VPPA is an important step in sourcing clean, renewable electricity to reduce the carbon footprint of our operations, so that we may play our part as a sustainable dairy processor and safeguard the environment for future generations.” Capital Power’s SVP and head of Canada, Jason Comandante, commented: “We are pleased to collaborate with industry leaders such as Saputo and Schneider Electric in delivering reliable, affordable, and decarbonised energy to our North American customer base. Through this agreement, we are again able to showcase our ability to collaborate and innovate, creating mutually beneficial partnerships to reduce emissions and support achieving broader climate change targets.” John Powers, VP of renewable energy and cleantech for Schneider Electric, added: “This collaboration between Saputo and Schneider Electric represents a global best practice for today’s needed energy transition, demonstrating the power of innovative partnerships and technology while also strengthening Saputo’s position as a leading sustainable dairy processor." The agreement is subject to final regulatory approvals.
- Voyage Foods raises $52m for allergen-free foods
San Francisco, Bay Area-based start-up Voyage Foods has closed a funding round totalling $52 million, bringing its total funding raised to $94 million. The round, which it considers a Series A+ round, was co-led by Level One Fund and Horizons Ventures, and saw participation from SOSV, Collaborative Fund and Nimble Partners. Voyage Foods combines breakthrough technology and upcycled wholesome ingredients to recreate favourite products and flavours that are free from the top nine allergens. It uses plant-based ingredients to develop sustainable and dairy-free alternatives to popular products that face ‘uncertain futures’ due to their sourcing challenges – including chocolate. Alongside its alternatives to cocoa-based products, it also provides nut-free spreads made without common nut or dairy allergens, such as peanut and hazelnut, formulated to taste like their traditional counterparts thanks to the company’s proprietary technology. The company says it will use the funding to address "greater than anticipated consumer and commercial demand" for its products accessed via B2B, foodservice and retail distribution channels. The capital will fund expanded manufacturing facilities and increased headcount to deliver on growth opportunities. As well as its sustainable, clean-label, cocoa-free chocolate, Voyage Foods produces bean-free coffee. B2B partners can utilise the coffee in various formats including cold brew, grounds, pods and instant, all crafted to maximise flavour, improve margins and deliver on sustainability initiatives. The start-up launched its peanut- and hazelnut-free spreads, made using roasted seeds, into Walmart stores across the US in October last year. In March this year, Voyage partnered with Rudi’s Mountain Bakery in the US on the launch of nut-free sandos, ready-to-eat sandwiches featuring Rudi’s grape jelly and Voyage’s peanut-free spread. In April, Voyage Foods signed a global deal with Cargill to supply commercial and B2B customers with sustainable confectionery. Under the deal, Cargill will be the exclusive B2B distributor for Voyage Foods, expanding its traditional chocolate portfolio to include cocoa-free alternatives for the first time. In recent months, cocoa prices have risen due to factors such as climate change, increased production costs and supply chain disruptions. According to Voyage Foods, the commodity's price has increased by 250% over the last year. "Voyage Foods enables manufacturers to bypass the chocolate industry’s growing supply chain disruptions and unethical labour practices," the company said in a statement. "By using upcycled ingredients that are less expensive to source, widely available and readily scalable, CPG partners can integrate Voyage Foods’ foods into their products and provide their customers with a delicious, environmentally beneficial experience at fair and stable pricing." “Voyage Foods was born out of the desire to harness the power of food technology and activate industry-wide change. We’re thrilled our innovations have been embraced within B2B and amongst a rapidly growing consumer base,” said Voyage Foods' CEO Adam Maxwell. “As a mission-driven food company, it’s especially fulfilling to work alongside investors that recognise and embrace our impact as we continue to move forward in further scaling manufacturing, expand distribution and deliver time-tested favourite foods that are better for the planet and our health.” Inge Demeyere, managing director of indulgence Europe at Cargill, added: “Cargill is proud to partner with Voyage Foods…this partnership is just one of the many ways that we are future-proofing our portfolio and meeting consumer demands and market regulations around sustainability and health." Level One's founding partner James Stewart said Voyage's technology “has set a new standard for commercialisation in the food-tech space by producing replicas of essential food products and ingredients that are both extremely cost competitive against, and more sustainable than, incumbent products.” He continued: “As the only company in the world with the validated ability to make these replicas at scale, Voyage’s newly announced partnership with Cargill makes these products available to the world’s major food companies as an immediate solution to fluctuating commodity prices and supply chain disruptions. Level One Fund is proud to co-lead this round with Horizons Ventures and provide the capital necessary for Voyage to scale up production and yield an immediate and meaningful impact on the world.”
- Q Mixers adds spicy mango margarita mix to portfolio
US beverage brand Q Mixers has added a spicy mango margarita mix to its portfolio. The new flavour features a base of rich organic agave and key limes, with juicy mango and bold, balanced spiciness from jalapeños. Q spicy mango margarita mix is the latest addition to join the brand's margarita portfolio, which includes Q margarita mix and Q spicy grapefruit margarita flavours. Bob Arnold, CEO of Q Mixers, said: "The margarita is the most ordered cocktail in the United States, which is why we're so excited to offer customers our new spicy mango margarita mix, a product we feel is well-positioned to become not just a summer staple but your go-to margarita mix". He added: "...we carefully crafted this from consumer feedback telling us to bring the sweet and bring the heat. We believe we found the perfect balance for everyone, elevating your favourite spirit or spirit-free alternative. Our spicy mango margarita mix delivers a bold flavour that matches our new look and feel and allows consumers to enjoy the perfect drink at home." Q spicy mango margarita mix is available via Amazon and at major retailers and grocers throughout the US.
- BioConsortia raises $15m in funding for advanced microbial solutions
US agri-tech company BioConsortia has raised $15 million in a funding round led by Otter Capital. BioConsortia specialises in the development of advanced microbial products aimed at protecting plants, enhancing fertility and boosting yields, while promoting agricultural sustainability. The funds will be used to expand the development of microbial products designed to increase crop yields through nitrogen or the management of nematode, fungal and soil insect pests. In addition, it will support expanded field trial programmes across key agricultural zones globally. The company said that with recent breakthroughs bolstering BioConsortia's leadership position in microbial gene editing, it also plans to invest in expanding its intellectual property portfolio. Moreover, BioConsortia intends to use the capital to expand its Davis, California, laboratory to accommodate its "growing microbial gene editing team". The funds will be allocated to upgrading fermentation and formulation capabilities at the Davis headquarters. This move aligns with the company's strategy as its biofungicide, bionematicide, postharvest decay control and nitrogen-fixing products approach commercialisation, this year. Marcus Meadows-Smith, BioConsortia CEO, said: “We have validated the consistency and impact of our nitrogen-fixing seed treatments through hundreds of field trials across a wide array of crops in recent years. This announced investment underlines our confidence that these technologies, with their extended shelf- and on-seed life, set a new standard for nitrogen-fixation products.”
- Enzyme solution targets reduction of acrylamide in coffee products
A new enzymatic solution, introduced by c-LEcta (part of the Kerry Group) and Anka (a platform focused on the coffee sector), is aimed at reducing acrylamide levels in soluble coffee products. Signifying an advancement in food safety, the Acrylerase solution is a patented enzyme technology that directly targets acrylamide, offering a promising alternative to existing mitigation methods. Acrylamide, a known carcinogen, forms during high-heat processes such as roasting and extraction, and is commonly found in the production of soluble coffee and coffee concentrates. The Acrylerase solution can efficiently decompose acrylamide on-site during processing, seamlessly integrating into existing manufacturing processes. Marc Struhalla, CEO of c-LEcta, said: “This innovative enzyme product offers a practical solution for soluble coffee manufacturers. Acrylerase can efficiently reduce acrylamide levels without compromising taste or disrupting production processes”. Jan Schwital, managing director of Anka, added: “We are excited to launch Acrylerase together with c-LEcta. We believe simplicity and efficiency are key to any successful industrial application. Acrylerase provides just that for controlling acrylamide in instant coffee and coffee extracts.” With regulatory bodies worldwide prioritising the mitigation of acrylamide in food, Acrylerase offers a timely solution for F&B manufacturers. Directives and regulations in countries such as South Korea and the EU are already in place, mandating the monitoring and reduction of acrylamide levels in various product categories, including soluble coffee. Oliver Süße-Herrmann, managing director of Anka, commented: “Acrylerase not only offers soluble coffee manufacturers a much simpler and more flexible way to comply with acrylamide regulations than was previously possible, but also enables usage of coffee volumes that may otherwise be rejected due to high acrylamide formation”.
- Roquette to acquire IFF Pharma Solutions in $2.85bn deal
Roquette has agreed to acquire IFF Pharma Solutions, a producer of ingredients for oral dosage solutions, for an enterprise value of up to $2.85 billion. IFF is a leading producer of excipients for oral dosage solutions in the pharmaceutical industry. It offers a wide range of high-quality products and serves pharmaceutical, food and nutraceutical companies worldwide. The acquisition is said to rebalance the Roquette's portfolio around health and nutrition, expand its pharma product range and accelerate its growth. In addition, it will expand Roquette's position in the excipients market, particularly in the US, and enhance its formulation capabilities and drug delivery research and development. Roquette's CEO, Pierre Courduroux, said: “After last year’s acquisition of Qualicaps, today’s announcement is a decisive step in our journey to reinforce our position in the health and nutrition markets". "The combination of our excipients’ expertise with IFF Pharma Solutions is a fantastic opportunity to become a true global specialist in drug delivery and oral dosage solutions. This responds to the needs of customers and patients looking for continuously better treatments. We very much look forward to welcoming IFF Pharma Solutions, and to jointly building the next chapter of our company’s growth history.” IFF's CEO, Erik Fyrwald, added: “We are pleased to reach an agreement with Roquette that will support Pharma Solutions’ next chapter of growth as a trusted partner for the pharmaceutical industry. An important next step in our portfolio optimisation strategy, the sale of Pharma Solutions, along with other recent actions...represents a significant step towards our commitment to reducing debt leverage to 3.0x or below. This also enables us to increase focus on the core drivers of long-term profitable growth and maximise value for our shareholders."
- Coca-Cola HBC Northern Ireland to acquire BDS Vending Solutions
Coca-Cola HBC Northern Ireland has agreed to acquire 100% of BDS Vending Solutions for an undisclosed sum. Founded in 1993, BDS Vending operates approximately 2,000 vending machines, providing food and beverage vending solutions in Ireland. Following the completion of the transaction, founders David Mullan and Brian Berry, have agreed to support the ownership transition of BDS Vending. According to the company, the acquisition of BDS Vending aligns with Coca-Cola HBC's strategy to improve its route-to-market capabilities, including last-mile delivery. It also offers opportunities across its diverse range of cold and hot beverages and snacks. Coca-Cola HBC said that BDS Vending offers "a valuable building block, with proven technology and services, from which Coca-Cola HBC plans to develop additional capabilities across its markets". The transaction is subject to approval by the Competition and Consumer Protection Commission in Ireland and is expected to be completed in the coming months. Terms of the deal were not disclosed.
- Interview: Yeast protein – a sustainable solution to the global protein crisis
In this interview, Angel Yeast Europe's global product manager, Winston Sun, explores the global protein crisis and highlights yeast protein as a sustainable solution. The company's innovative approach to yeast protein production addresses environmental concerns while meeting nutritional demands. The versatility of yeast protein extends beyond traditional uses, offering applications in various food sectors. Sun tells us more. What are the United Nations' predictions for global population growth? The United Nations predicts that the global population will reach 9.7 billion by 2050, and the situation may worsen. By 2050, population growth is expected to lead to a shortage of 250 million tons of protein. Filling this gap by increasing livestock production would exacerbate global warming and increase the land required for food production, resulting in sustained negative environmental impacts. Why is yeast regarded as such a compelling solution to this issue? The fascinating aspect of yeast lies in its small fungal nature, containing a vast world within it that is intricately intertwined with our daily lives. For instance, yeast is responsible for fermenting the bread we eat and the beverages we drink. It can be found in extracts used in cosmetics, seasonings in our daily cooking and as a beneficial probiotic aiding in gut health regulation. Functional components like glutathione and yeast polysaccharides can be extracted from yeast. Additionally, the wastewater from yeast fermentation serves as an environmentally friendly organic fertiliser. Yeast presents many captivating facets awaiting exploration. Beyond its conventional roles in bread-making and brewing, what other potentials does yeast hold? Beyond baking and brewing, Angel Yeast harnesses the full potential of yeast extracts to offer a range of differentiated advantages in food ingredient applications. Our products are tailored to enhance flavours, reduce salt, mask off-notes and cater to vegetarian preferences, meeting the evolving demands of the global food and beverage sectors. These versatile extracts find application in various products such as soups, instant noodles, snacks, meat and dairy alternatives, and functional foods, aligning with the rising consumer preference for natural, nutritious and delicious upgrades in their diets. Angel Yeast plays a key role in human nutrition and health through offerings such as yeast protein, Boulardii yeast probiotics and yeast enriched with essential nutrients like zinc, selenium and chromium. With a focus on large-scale production, Angel Yeast has successfully incorporated yeast protein into flavourings, meat substitutes, dairy alternatives and functional nutrition products. The company has an annual production capacity of 1,000 tons of yeast protein, with plans to expand to 10,000 tons per year. How does yeast protein contribute to addressing the global future protein crisis? Angel Yeast's development of yeast protein presents a sustainable, environmentally friendly and nutritionally rich solution to the global protein crisis. Unlike traditional crop-based protein sources, the microbial fermentation process for yeast protein is both sustainable and scalable, offering a reliable supply unaffected by weather conditions. With the capacity to produce approximately 30 tons of microbial protein per day in a large fermentation tank of 1,000 cubic meters, this equals the annual protein output of 100,000 to 300,000 acres of soybeans. We select brewing yeast with optimal biomass and growth rates as the initial strain, employing high-throughput screening and directional breeding to achieve high-yield, stable protein strains. We utilise advanced compound enzyme hydrolysis technology for protein purification, enhancing its application characteristics for various food systems through enzymatic hydrolysis or physical modification. What are the environmental benefits? Yeast protein production significantly reduces water consumption, occupies less arable land and generates fewer carbon footprints. The wastewater generated from yeast protein production is used as organic fertiliser for yeast crops, creating a circular economy. What special qualities does yeast protein possess as an organism? Yeast protein is a natural, clean-label ingredient suitable for vegetarians, non-GMO, and allergen-free. It boasts abundant high-quality protein, dietary fibre, complete B vitamins, various minerals, and other beneficial nutrients. With low sugar, fat, calories and cholesterol-free characteristics, it offers a nutritious option for health-conscious consumers. Could you describe the nutritional composition of yeast protein – especially compared to traditional proteins? Whey protein – currently the gold standard – offers rapid digestion and a complete amino acid profile, particularly rich in branched-chain amino acids (BCAAs) and leucine. However, its animal-derived nature may not suit all consumers seeking dairy-free or plant-based alternatives. Plant-based proteins, while available, often lack essential amino acids and may be challenging to digest fully. Additionally, their production from sources like wheat, soy and peas demands significant land use and is susceptible to weather fluctuations. Enter yeast protein, derived from brewing yeast, boasting over 70% high-quality protein and a leucine content comparable to whey. Its 'slow protein' nature provides a sustained amino acid release, complemented by functional polysaccharides beneficial for gut health. Yeast protein production also offers sustainability advantages, requiring less land and utilising wastewater as organic fertiliser for yeast crops, thus fostering a circular economy. Therefore, yeast protein effectively addresses barriers for consumers purchasing animal protein supplements and also addresses sustainability issues. What are the main applications of yeast protein? As a high-quality protein source, yeast boasts wide-ranging applications across various sectors: Common foods: yeast is utilised for nutritional fortification, fermentation in baked goods and enhancing stability and texture in products like bread, meat substitutes, dairy beverages and plant-based alternatives. In plant-based meat applications, yeast protein can mask 'beany' flavours, improve meaty taste, boost protein content and enhance texture to mimic real meat. Functional foods: yeast protein is also prominent in protein powders, energy bars and sports nutrition products. It supports muscle recovery and reduces fatigue, making it valuable for consumers seeking active lifestyle solutions. Could you elaborate on the findings from your clinical trials involving yeast protein? Angel Yeast conducted a double-blind randomised controlled trial on 79 healthy adults 40 and above in Australia. The participants received 40g of yeast protein, whey protein or a placebo daily and participated in an eight-week resistance training programme targeting major muscle groups. In participants with insufficient dietary protein intake, yeast protein and whey protein significantly increased lean muscle mass and muscle strength compared to the placebo. The maximum bench press strength increased by 5.78kg and 5.77kg in the yeast protein and whey protein groups, respectively, while the placebo group only showed an increase of 2.59kg. This study revealed that yeast protein is as effective as the gold standard whey protein in increasing muscle mass and strength in the elderly during exercise. Find out more here.
- Incredo introduces concentrated sugar reduction solution
Food-tech company Incredo has launched Incredo Sugar G2, a concentrated version of its sugar-based reduction solution, Incredo Sugar. The latest addition to Incredo’s range of sugar reduction solutions, Incredo Sugar G2 is a clean-label, patent-pending concentrated sugar-carrier complex crafted from a blend of real sugar (derived from cane or beet) and protein. Available in both plant-based and dairy-based options, it caters to various dietary preferences and manufacturers seeking clean-label ingredients. As it's derived from sugar, Incredo Sugar G2 preserves the sweetness and sensory characteristics of sugar without any lingering aftertaste, while using up to 50% less sugar content. Offering versatility, it seamlessly integrates into recipes without the need for a complete sugar replacement. This allows it to be added alongside the current sugar supply as a micro-ingredient, without requiring alterations to procurement or supply chain processes. Moreover, its concentrated form enables more sustainable production, storage and manufacturing in smaller quantities. Kelly Thompson, co-CEO and commercial head for Incredo, stated: “Our aim when working with food manufacturers to achieve their sugar reduction goals is to offer a solution that suits their specific needs. This latest addition to our product portfolio provides another option for our partners that allows seamless integration into the manufacturing process, while leveraging our innovative technology.”David Tsivion, co-CEO and chief technology officer for Incredo, added: “We’re committed to providing innovative solutions which deliver sugar-reduced food products that are both tasty and nutritious. As we expand our ingredient portfolio with the launch of Incredo Sugar G2, we’ll continue to uphold our commitment to providing a full end-to-end solution, including providing our partners with guidance on any necessary recipe reformulation, bulking and production know how and strategic optimisations specific to desired food applications.” Earlier this year, Incredo received a 'no questions' response letter from the US Food & Drug Administration for the Generally Recognized as Safe (GRAS) notice submitted by the company, signifying the safety of Incredo Sugar G2 for use in food products. Incredo Sugar G2 is now available to companies in the US & Europe, enabling incorporation into a wide range of products such as baked goods, chocolates, spreads and gummies.












